Exactly. By assigning a 5% success, considering almost no type I error was spent at the interim, Martin claims the median OST in the control arm is identical to the stimuvax at a 33-38 months. I just can't see how he can make that statement unless he has insider knowledge. That's what I disagree. I would hope Dr. Butts was right when he estiamted the patient population at 25-month.
Market Data 
Markets 
AI
